Skip to main content
Loading ResearchHub…
Cited by — Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease | ResearchHub - ResearchHub